Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1Gastrointestinal 1

Conditions

Stomatitis 2Head and Neck Neoplasms 2Stomatognathic Diseases 1Neoplasms by Site 1Neoplasms 1Mucositis 1Mouth Diseases 1Gastrointestinal Diseases 1Gastroenteritis 1Digestive System Diseases 1

Interventions

Cisplatin 4angiotensin I (1-7) 3Radiotherapy 3Radiation 3Injections 3Water 2RRx-001 2Interleukin 1 Receptor Antagonist Protein 2Drug Therapy 2Amifostine 2tempol 1peppermint oil 1pegfilgrastim 1kang-lai-te 1hydrated silica gel-based toothpaste 1golotimod 1glucarpidase 1fish oil triglycerides 1calcium phosphate 1brilacidin 1anise oil 1amlexanox 1aluminum hydroxide, magnesium hydroxide, drug combination 1Xylitol 1Vaccinium myrtillus extract 1Tramadol 1Therapeutics 1Surgical Procedures, Operative 1Sorbic Acid 1Sodium Bicarbonate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Mucositis × golotimod × Clear all
NCT01247246 2014-05-26

Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer

SciClone Pharmaceuticals

Phase 2 Unknown
160 enrolled
GastrointestinalHead & NeckOther

Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, Head and Neck Neoplasms, Stomatognathic Diseases, Mouth Diseases, Neoplasms, Neoplasms by Site, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡